Table 5.
FUS | sTS | iPL | iPS | PRE | iFG | |
---|---|---|---|---|---|---|
Regional connections (A matrix): control subjects | ||||||
FUS | ||||||
sTS | 0.1505 | 0.0095 | 0.0208 | 0.0345 | 0.0745 | |
iPL | −0.0812 | −0.1191 | ||||
iPS | ||||||
PRE | 0.1395 | 0.0408 | ||||
iFG | 0.1397 | 0.0948 | 0.1004 | −0.0916 | 0.0372 | |
Regional connections (A matrix): PPA subjects | ||||||
FUS | ||||||
sTS | 0.0306 | −0.0178 | −0.0116 | 0.0636 | 0.0744 | |
iPL | −0.0165 | −0.1139 | ||||
iPS | ||||||
PRE | 0.1660 | 0.0517 | ||||
iFG | 0.1339 | 0.0647 | 0.0742 | −0.0835 | 0.0859 | |
Modulatory effect of SYN (B matrix): control subjects | ||||||
FUS | ||||||
sTS | 0.1381 | −0.0033 | 0.0698 | 0.0114 | 0.0179 | |
iPL | 0.1383 | 0.0637 | ||||
iPS | ||||||
PRE | 0.1328 | 0.0426 | ||||
iFG | 0.2430 | 0.0339 | −0.0076 | 0.1211 | 0.0353 | |
Modulatory effect of LETTER (B matrix): control subjects | ||||||
FUS | ||||||
sTS | −0.0785 | 0.0138 | −0.0654 | −0.0053 | 0.0041 | |
iPL | −0.1591 | −0.1204 | ||||
iPS | ||||||
PRE | −0.0130 | 0.0155 | ||||
iFG | −0.1503 | −0.0100 | 0.0310 | −0.1075 | −0.0165 | |
Modulatory effect of SYN (B matrix): PPA patients | ||||||
FUS | ||||||
sTS | 0.0494 | −0.0002 | 0.0139 | 0.0055 | 0.0021 | |
iPL | 0.0588 | 0.0183 | ||||
iPS | ||||||
PRE | 0.1495 | 0.0471 | ||||
iFG | 0.2159 | 0.0165 | −0.0119 | 0.0801 | 0.0471 | |
Modulatory effect of LETTER (B matrix): PPA patients | ||||||
FUS | ||||||
sTS | −0.0704 | 0.0117 | −0.0574 | −0.0115 | 0.0026 | |
iPL | −0.1355 | −0.0919 | ||||
iPS | ||||||
PRE | −0.0566 | −0.0147 | ||||
iFG | −0.1219 | 0.0019 | 0.0169 | −0.0811 | −0.0167 |
Bold indicates significance at p < 0.05, corrected. Italics indicates significance at p < 0.05, uncorrected.